Commercialization


Souroubea Inc anxiolytic (ZENTROL™) for dogs is currently in the US pet marketplace under an exclusive distribution agreement with Central Garden & Pet. The product effectiveness, evidenced through controlled studies and evidence from marketplace use and repeat sales, has formed the basis for growth of the company.
We are planning for distribution of the anxiolytic in other geographic markets. In addition, we are seeking to establish collaboration with industrial partners or investors to develop/commercialize our novel, highly effective and safe plant-derived anti-anxiety treatments for the Equine, Poultry, Livestock and Aquaculture sectors

Based upon the efficacy in animals and proven safety in the marketplace we have embarked upon a program to develop our natural product-based anxiolytic for human use. We welcome potential development partners